Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Review Article

IJMDC. 2020; 4(1): 244-252

Ethical considerations in doctors & pharmaceutical industries relationship: a narrative review

Mohammed Saud Almasri, Yousef Rafat Bukhari, Bandar Saleh Alzuair, Mansour Khalid Almadi, Amro Khalid Bin Abdulrahman.

The Physicians-Drug Representative (PDR) relationship is a concerning ethical issue in the medical field. Negative effects resulting from these interactions affect major aspects of health institutions, such as knowledge of physicians and their prescribing practices. A better understanding of PDR interactions could be a key factor in minimizing the negative outcomes. The aim of this review was to discuss the PDR relationship from an ethical point of view and to give a better picture of what the current literature says. We performed a literate search in the databases (PubMed, Science Direct, MEDLINE, and Google Scholar) using the terms "Physicians-Drug Representative Relationship" "Medical Ethics" "Gift Acceptance" "Change in Knowledge" "Prescribing Behavior" "Interest Conflicts" "Physician-Patient Relations" "Pharmaceutical Marketing" to identify relevant articles. Subheadings were chosen and discussed in this review based on common measurements of previous related articles. The review showed that the interactions between the physicians and the pharmaceutical companies have multiple effects on physicians from different aspects, ranging from minimal changes in knowledge
into irrational changes in practice. Apparently, there is a need for more focus on the training programs of physicians regarding PDR interactions. Further studies should also focus on PDR implications on patients' perceptions and their general health status.

Key words: Physicians-drug representative relationship, medical ethics, gift acceptance, change in knowledge, prescribing behavior, conflict of interest, health care system, doctor-patient trust, pharmaceutical marketing

Similar Articles

Using the Health Belief Model to examine travelers' willingness to vaccinate and support for vaccination requirements prior to travel.
Suess C, Maddock J, Dogru T, Mody M, Lee S
Tourism management. 2022; 88(): 104405

Environmental stocks, CEO health risk and COVID-19.
Fernández-Méndez C, Pathan S
Research in international business and finance. 2022; 59(): 101509

Health-seeking behaviour, views and preferences of adults with suspected increased intestinal permeability: A cross-sectional survey of Australian adults.
Leech B, McIntyre E, Steel A, Sibbritt D
Integrative medicine research. 2022; 11(1): 100757

Health technology assessment and economic evaluation: Is it applicable for the traditional medicine?
Chen Y
Integrative medicine research. 2022; 11(1): 100756

Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, Díaz de León-Martínez L, Rodríguez-Aguilar M, Mizaikoff B, Flores-Ramírez R
Talanta. 2022; 236(): 122832

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites